DCs can recognize tumor-specific antigens and activate CD8 + T cells via T cell receptor (TCR) signaling, leading to the release of IFN-γ by activated T cells, which subsequently induces ferroptosis in cancer cells [80]. The gene discussed is CD8A; the disease is neoplasm.